Vera Therapeutics, Inc.
VERA
$39.96
-$1.21-2.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -299.62M | -251.94M | -218.28M | -175.46M | -152.15M |
| Total Depreciation and Amortization | 468.00K | 388.00K | 283.00K | 179.00K | 105.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.05M | 29.36M | 23.65M | 18.18M | 14.70M |
| Change in Net Operating Assets | 22.99M | 11.90M | 9.08M | 1.84M | 2.66M |
| Cash from Operations | -241.10M | -210.29M | -185.27M | -155.26M | -134.68M |
| Capital Expenditure | -630.00K | -1.17M | -1.28M | -1.16M | -972.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 194.92M | -106.59M | -137.93M | -189.27M | -424.06M |
| Cash from Investing | 194.29M | -107.76M | -139.21M | -190.43M | -425.03M |
| Total Debt Issued | 23.34M | 23.34M | 23.34M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 306.98M | 350.11M | 350.06M | 353.04M | 645.91M |
| Repurchase of Common Stock | -- | 0.00 | -13.00K | -13.00K | -13.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.42M | -24.87M | -24.87M | -21.36M | -39.23M |
| Cash from Financing | 308.90M | 348.57M | 348.51M | 331.67M | 606.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 262.08M | 30.52M | 24.04M | -14.02M | 46.97M |